EMA recommends temporarily restricting Lemtrada use in MS
The review comes following new reports of immune-mediated conditions.
Read More
Tag: review
Health secretary orders review of overprescribing
Health secretary Matt Hancock has ordered a review of patients who take multiple medicines, to ensure they are receiving the most appropriate treatment for their needs, and avoid needless overprescribing.
Read More
Cannabis-based meds beneficial for some conditions, finds UK review
The UK’s chief medical officer and advisor Professor Dame Sally Davies has concluded that there is evidence to show the therapeutic benefit of cannabis-based medicines for some conditions.
Read More
UK announces review of medicinal cannabis
Home secretary Sajid Javid has announced a review of medicinal cannabis in the UK, in response to growing pressure to allow use of cannabis oil to help control seizures in children with severe forms of epilepsy.
Read More
Shire to split operations in two
Shire has unveiled plans to split its operations into two separate entities – a neuroscience division and rare diseases one, and will later decide whether they should be listed independently.
Read More
US beats EU on drug review times, approvals
US regulators have outpaced their European counterparts both on the number of new medicines approved and length of review times between 2011 and 2015, shows a new analysis published by the New England Journal of Medicine.
Read More
New reforms for Scottish medicines approval process
The Scottish government has announced plans for new reforms to the way treatments are approved in the country, to help boost access for patients.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
